Innovent Biologics

2 followers


Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company's main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303.

Industries

Headquarters

Suzhou, China

Employees

1,001-5,000

Links


Org chart

Yu Dechao
Founder, Chairman & CEO
Collapse
Liu Yongjun
President
Gao Changshou
Chief Technology Officer & SVP
Xi Hao
Executive Director & CFO
Zhang Qian
Chief Talent Officer
Yong Jun Liu
President
Guoqiang Hu
Senior Vice President
Kenneth Kang
Suzhou M1 General Manager, Senior VP
Kaiming Wei
Senior Legal Counsel
Ronnie Zhang
Sr. Engineering Opertaion Director

Board & advisors

Chen Kaixian
Independent Non-executive Director
Xu Yiyin
Independent Non-executive Director
Charles L. Cooney
Independent Non-Executive Director
Gary Zieziula
Independent Non-executive Director